Medical Devices & Optical Products / Semiconductor Manufacturing Equipment
Strategic Profile
Hoya holds more than 60% market share in semiconductor mask blanks and over 75% in EUV lithography mask blanks, with its IT business accounting for less than 30% of revenue but generating more than half of earnings. As semiconductor miniaturization continues and EUV technology becomes more indispensable, high-value-added EUV mask blanks are expected to drive profit growth over the next decade.
Cyborg Score Rationale
Hoya demonstrates exceptional competitive moats through dominant market positions in high-margin semiconductor mask blanks (60-75% market share), strong financial metrics with 20.86% ROE, and solid cash generation. Growth drivers from EUV lithography adoption and medical device expansion support medium-term upside.
Top Insights
More than 75% global market share in EUV mask blanks—a critical enabler for advanced chip manufacturing with limited competition
Life Care segment (60%+ revenue) faces lower margins but diversifies into high-growth medical device categories
Strong balance sheet with 496.68B JPY net cash position and 4.90 current ratio provides capital for M&A and R&D investment
Low beta (0.61) indicates defensive characteristics attractive during market volatility
Named Competitors
Carl Zeiss — Optical systems and eyewear
Essilor — Eyeglass lenses and optical retail
Johnson & Johnson Vision — Contact lenses and eye care
Nikon — Photomasks and semiconductor equipment
Recent Developments
(FY2025) Revenue increased 13.56% to 866.03B JPY with strong profit growth driven by semiconductor demand
(Recent) Continued investment in eyeglass lens consumer brands to enhance gross margins through branding premiums
(Ongoing) Expansion of medical product portfolio with focus on surgical instruments and endoscopic equipment
Open the full interactive Hoya Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.